The perils of PCR: can we accurately 'correct' antimalarial trials?
about
Drug-resistant genotypes and multi-clonality in Plasmodium falciparum analysed by direct genome sequencing from peripheral blood of malaria patientsExposing malaria in-host diversity and estimating population diversity by capture-recapture using massively parallel pyrosequencing.Declining responsiveness of Plasmodium falciparum infections to artemisinin-based combination treatments on the Kenyan coastPlasmodium vivax Diversity and Population Structure across Four ContinentsEstimating the numbers of malaria infections in blood samples using high-resolution genotyping data.How much remains undetected? Probability of molecular detection of human Plasmodia in the fieldEnhanced understanding of infectious diseases by fusing multiple datasets: a case study on malaria in the Western Brazilian Amazon regionLong term persistence of clonal malaria parasite Plasmodium falciparum lineages in the Colombian Pacific regionDetection of persistent Plasmodium spp. infections in Ugandan children after artemether-lumefantrine treatment.Relevance of undetectably rare resistant malaria parasites in treatment failure: experimental evidence from Plasmodium chabaudi.Plasmodium falciparum population dynamics during the early phase of anti-malarial drug treatment in Tanzanian children with acute uncomplicated malaria.Genetic Diversity of Plasmodium falciparum Populations in Malaria Declining Areas of Sabah, East Malaysia.Robust Algorithm for Systematic Classification of Malaria Late Treatment Failures as Recrudescence or Reinfection Using Microsatellite Genotyping.Culture-adapted Plasmodium falciparum isolates from UK travellers: in vitro drug sensitivity, clonality and drug resistance markers.Species and genotype diversity of Plasmodium in malaria patients from Gabon analysed by next generation sequencing.Residual Plasmodium falciparum parasitemia in Kenyan children after artemisinin-combination therapy is associated with increased transmission to mosquitoes and parasite recurrenceReply to "no robust evidence of lumefantrine resistance".Malaria haplotype frequency estimation.Putting evolution in elimination: Winning our ongoing battle with evolving malaria mosquitoes and parasites.Drug Resistance and Population Structure of Plasmodium falciparum Across the Democratic Republic of Congo using high-throughput Molecular Inversion Probes.Comparison of Two Genotyping Methods for Distinguishing Recrudescence from Reinfection in Antimalarial Drug Efficacy/Effectiveness Trials.Identifying Recrudescent Plasmodium falciparum in Treated Malaria Patients by Real-time PCR and High Resolution Melt Analysis of Genetic Diversity.
P2860
Q21091002-5EE15076-FFF4-40FD-9662-77D9340EA4C7Q24633707-B21DEA8A-19FB-4916-B437-EA1DABB37676Q28477892-0801AF4C-2FC8-4878-9170-898C5C948990Q28545982-20B25007-358B-42EE-B322-6511B35E1E09Q30561882-0AB5604F-2997-4996-A0E8-ED4B2953E529Q33892663-C7BA0EB2-8DC2-4185-B89B-13173336FFA9Q34075704-2D9252C5-3D96-41A3-8A1A-760596FCAB29Q34538134-297E76F3-2CAD-4717-B2D5-4A66F85AC58BQ34629332-2D8146BA-CD3F-4212-BB47-4A4BCD37E12AQ35692528-21A2AFF0-B4F3-45D6-90E0-314B24EA975DQ35761064-5DAEB50E-9652-4A60-9579-6E40C2448C89Q35972930-AA2923E2-B5FA-4F64-9D89-2B145F3879DCQ36075776-C7A95E12-8544-4246-BB3B-21D769FC9A05Q37357025-97792437-5B90-4A9D-9F0A-24FF28D19A95Q41991520-B8251DE2-002F-44A5-BDCA-CB4483BF6524Q42127740-73E971E0-74B9-4E6B-98AC-7CAF54FDBAD4Q42545563-A2665160-DBB8-4CC6-880E-91ED3B219CCBQ46633417-B8788806-2030-433B-BFBA-E02035830676Q52595160-05E8EA5C-3DA8-4138-8A8F-3B2360AA7B27Q53689124-EE79F3BF-ED79-40B6-9771-3D1E2459ECB1Q54203227-DD477725-AC2D-4054-87C4-90F3410C7F16Q55669580-39780482-0553-4332-86B4-9C83C57D01B9
P2860
The perils of PCR: can we accurately 'correct' antimalarial trials?
description
2010 nî lūn-bûn
@nan
2010 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի մարտին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
The perils of PCR: can we accurately 'correct' antimalarial trials?
@ast
The perils of PCR: can we accurately 'correct' antimalarial trials?
@en
The perils of PCR: can we accurately 'correct' antimalarial trials?
@nl
type
label
The perils of PCR: can we accurately 'correct' antimalarial trials?
@ast
The perils of PCR: can we accurately 'correct' antimalarial trials?
@en
The perils of PCR: can we accurately 'correct' antimalarial trials?
@nl
prefLabel
The perils of PCR: can we accurately 'correct' antimalarial trials?
@ast
The perils of PCR: can we accurately 'correct' antimalarial trials?
@en
The perils of PCR: can we accurately 'correct' antimalarial trials?
@nl
P2860
P50
P3181
P356
P1476
The perils of PCR: can we accurately 'correct' antimalarial trials?
@en
P2093
Jonathan J Juliano
P2860
P304
P3181
P356
10.1016/J.PT.2009.12.007
P407
P577
2010-03-01T00:00:00Z